We are live on ! Find out more
BFM

Boston Financial Management Portfolio holdings

AUM $3.31B
1-Year Est. Return 19.4%
This Fund
S&P 500
This Quarter Est. Return
-10.94%
1 Year Est. Return
+19.4%
3 Year Est. Return
+30.07%
5 Year Est. Return
+107.8%
10 Year Est. Return
+274.5%
AUM
$1.44B
AUM Growth
-$250M
Cap. Flow
-$44.8M
Cap. Flow %
-3.11%
Top 10 Hldgs %
24.83%
Holding
306
New
8
Increased
76
Reduced
141
Closed
50

Sector Composition

Rank Sector Weight
1 Healthcare 17%
2 Technology 15.6%
3 Industrials 11.4%
4 Financials 11.27%
5 Consumer Staples 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSV icon
76
FirstService
FSV
$6.21B
$5.78M 0.4%
84,430
-36,045
-30% -$2.69M
NKE icon
77
Nike
NKE
$61.6B
$5.48M 0.38%
73,961
-1,758
-2% -$132K
MRK icon
78
Merck
MRK
$316B
$5.2M 0.36%
71,259
-1,015
-1% -$71.7K
FAST icon
79
Fastenal
FAST
$57B
$5.01M 0.35%
383,512
+19,260
+5% +$261K
SPY icon
80
State Street SPDR S&P 500 ETF Trust
SPY
$821B
$4.75M 0.33%
19,006
-738
-4% -$199K
AMT icon
81
American Tower
AMT
$81.7B
$4.69M 0.32%
29,637
-5,040
-15% -$788K
EMR icon
82
Emerson Electric
EMR
$89B
$4.41M 0.31%
73,794
-2,037
-3% -$137K
ABT icon
83
Abbott
ABT
$182B
$4.1M 0.28%
56,734
-1,641
-3% -$115K
CSCO icon
84
Cisco
CSCO
$480B
$3.9M 0.27%
89,935
-3,844
-4% -$176K
AMGN icon
85
Amgen
AMGN
$210B
$3.86M 0.27%
19,823
-2,884
-13% -$563K
VIG icon
86
Vanguard Dividend Appreciation ETF
VIG
$114B
$3.8M 0.26%
38,766
-3,113
-7% -$325K
IVV icon
87
iShares Core S&P 500 ETF
IVV
$900B
$3.7M 0.26%
14,698
-2,238
-13% -$608K
SYK icon
88
Stryker
SYK
$129B
$3.65M 0.25%
23,286
-415
-2% -$69.4K
TMO icon
89
Thermo Fisher Scientific
TMO
$209B
$3.65M 0.25%
16,302
-304
-2% -$71.3K
SMG icon
90
ScottsMiracle-Gro
SMG
$3.86B
$3.29M 0.23%
53,521
-33,229
-38% -$2.36M
AZN icon
91
AstraZeneca
AZN
$241B
$3.25M 0.23%
42,780
-495
-1% -$38.7K
RTX icon
92
RTX Corp
RTX
$294B
$3.14M 0.22%
46,834
+1
+0% +$78
INTC icon
93
Intel
INTC
$509B
$3.04M 0.21%
64,797
-2,942
-4% -$138K
MCD icon
94
McDonald's
MCD
$191B
$2.94M 0.2%
16,537
-670
-4% -$119K
CVS icon
95
CVS Health
CVS
$133B
$2.77M 0.19%
42,340
+185
+0.4% +$13.8K
GTT
96
DELISTED
GTT Communications, Inc.
GTT
$2.77M 0.19%
117,235
-93,707
-44% -$3.15M
RPM icon
97
RPM International
RPM
$14.7B
$2.75M 0.19%
46,783
-1,920
-4% -$118K
SHY icon
98
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$2.63M 0.18%
31,403
-1,630
-5% -$135K
EXAS
99
DELISTED
Exact Sciences
EXAS
$2.59M 0.18%
41,069
KO icon
100
Coca-Cola
KO
$372B
$2.56M 0.18%
54,160
-3,532
-6% -$169K

Similar funds

Boston Financial Management's Q4 2018 Portfolio in Review

As of Q4 2018, Boston Financial Management held 306 positions worth $1.44B, down 15% from $1.69B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Boston Financial Management withdrew a net $44.8M in Q4 2018, closing 50 positions and reducing 141 holdings. Its most notable exit was Luxottica Group, an estimated $22.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.

Against the trend, Boston Financial Management opened a new position in WisdomTree Emerging Markets SmallCap Dividend Fund worth $12.9M.

  • Boston Financial Management's largest Q4 2018 buy was WisdomTree Emerging Markets SmallCap Dividend Fund: 307,476 shares worth $12.9M.
  • Boston Financial Management added most to iShares MSCI EAFE ETF in Q4 2018, an estimated $18M increase.
  • Boston Financial Management's biggest Q4 2018 reduction was Goldman Sachs ActiveBeta International Equity ETF, cutting an estimated $18.7M.
  • Boston Financial Management fully exited Luxottica Group in Q4 2018, selling an estimated $22.6M.
  • Boston Financial Management's ten largest holdings make up 25% of its $1.44B portfolio in Q4 2018.
  • Boston Financial Management opened 8 new positions and closed 50 in Q4 2018.
  • Boston Financial Management's portfolio value fell 15% quarter-over-quarter to $1.44B.

Based on Boston Financial Management's 13F filing for Q4 2018, filed 31 Jan 2019.